Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

What fueled the previous growth in the metabolic biomarker testing market?

The market size for metabolic biomarker testing has seen a robust growth recently. The market is forecasted to cultivate from $2.82 billion in 2024 to $3.06 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. This growth in the historical phase can be credited to the escalating occurrence of metabolic ailments, amplified awareness regarding early detection of diseases, burgeoning demand for custom-made medicine, a spike in obesity and diabetes cases, and the expanding embracement of preventative healthcare methods.

What will be the metabolic biomarker testing market size in the future?

In the coming years, the market size for metabolic biomarker testing is projected to witness significant growth. By 2029, it is anticipated to reach $4.2 billion, growing at a compounded annual growth rate (CAGR) of 8.3%. This growth during the forecast period can be credited to several factors including an enhanced focus on precision medicine, the expansion of personalized nutrition and wellness programs, an increase in funds allocated for metabolic research, improvement in patient awareness and education, and a surge in metabolic syndrome cases and related conditions. Key trends for the forecast period comprise of advancements in high-throughput screening technologies, the merging of machine learning in biomarker analysis, the application of artificial intelligence, progress in mobile health (mHealth) technologies, and the growth of telemedicine solutions for remote biomarker testing.

Get your metabolic biomarker testing market report here!

https://www.thebusinessresearchcompany.com/report/metabolic-biomarker-testing-global-market-report

What main drivers are fueling expansion in the metabolic biomarker testing market?

The escalation in diabetes occurrences is anticipated to boost the expansion of the metabolic biomarker testing market in the future. Diabetes is a long-term health condition marked by elevated blood sugar levels as a result of the body’s inability to produce or utilize insulin effectively. The surge in diabetes is attributed to unhealthy food habits, primarily overconsumption of processed food and sugary beverages, and inactive lifestyles marked by insufficient physical exercise. Additionally, the growing elderly population and family diabetes history elevate the risk, suggesting a genetic link. Metabolic biomarker testing aids in diagnosing, tracking, and managing metabolic disorders like diabetes by offering insights into the molecular level of metabolic processes and discrepancies. For instance, as per the British Diabetic Association, a non-profit organization based in the U.K, in May 2024, 4.3 million people are presently diagnosed with diabetes in the UK, a rise of 148,951 registered cases in 2022 compared to 2021. Furthermore, more than 2.4 million individuals in the UK are at a significant risk of developing type 2 diabetes. Hence, the escalating diabetes incidence will propel the metabolic biomarker testing market’s progress.

What key areas define the segmentation of the global metabolic biomarker testing market?

The metabolic biomarker testing market covered in this report is segmented –

1) By Type: Separation Techniques, Detection Techniques, Other Types

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications

3) By Application: Drug Assessment, Nutrigenomics, Toxicology Testing, Personalized Medicine, Functional Genomics, Other Applications

4) By End User: Pharma And Biotech Companies, Diagnostic Tool Companies, Healthcare Information Technology (IT), Clinical Laboratories

Subsegments:

1) By Separation Techniques: Chromatography, Capillary Electrophoresis, Mass Spectrometry (MS), Liquid-Liquid Extraction, Solid-Phase Extraction

2) By Detection Techniques: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Fluorescence-Based Detection, Electrochemical Detection, Nuclear Magnetic Resonance (NMR), Immunoassays

3) By Other Types: Genetic Biomarker Testing, Protein Biomarker Testing, Metabolomics Profiling, Spectroscopy Techniques, Microarray Technology

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20573&type=smp

Who are the dominant players expanding their reach in the metabolic biomarker testing market?

Major companies operating in the metabolic biomarker testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., bioMérieux S.A., LECO Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, SCIEX, Promega Corporation, Cayman Chemical Company, Metabolon Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., KineMed Inc., Evosep Biosystems A/S, Creative Proteomics Inc., Lipotype GmbH, Metabolomic Diagnostics Ltd, Stemina Biomarker Discovery Inc., Chenomx Inc., GlycoPath Pty Ltd

How are evolving market trends shaping metabolic biomarker testing Strategies?

Top firms in the metabolic biomarker testing market are concentrating on technological improvements, such as biowearables for self-monitoring. These advancements allow individuals to continuously assess and manage their nutritional and health statuses. Biowearables offer real-time, non-invasive tracking of crucial metabolic indicators like glucose, which aid in personalized health management and optimal dietary and athletic performance. For example, US-based medical device company, Abbott Laboratories, in January 2022, introduced the Lingo biowearable, designed to be worn on the upper arm for up to a fortnight, to facilitate user monitoring of glucose, ketone, and lactate levels. This device provides an ongoing examination of metabolic health while harnessing the technology from Abbott’s FreeStyle Libre for wellness enhancement and athletic performance improvement, rather than medical diagnostic usage. Its preliminary launch is set for Europe under the Lingo Keto brand, making it readily available to consumers without requiring a prescription.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20573

Which regions are emerging as leaders in the metabolic biomarker testing market?

North America was the largest region in the metabolic biomarker testing market in 2024. The regions covered in the metabolic biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: